GlassScriptPhysician profile
Lawrence Robert Tenkman
NPI 1023207859
$5,041.74
in general payments reported to CMS, 2019-2025
29 companies · $679 in 2025
The $679 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $341 · 2021: $316 · 2022: $709 · 2023: $1,184 · 2024: $1,042 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,905.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,173.09 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $492.56 | 2019-2024 | Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $255.61 | 2024-2025 | Xdemvy |
| Abbvie INC. | $250.78 | 2022-2025 | Xen Glaucoma Treatment System, Alphagan P, Lumigan |
| Allergan, INC. | $217.45 | 2019-2021 | |
| Ocular Therapeutix, INC. | $202.74 | 2023-2024 | Dextenza |
| Biotissue Holdings INC. | $163.31 | 2020-2024 | |
| Sun Pharmaceutical Industries INC. | $159.44 | 2019-2023 | Cequa |
| Mallinckrodt Hospital Products INC. | $134.67 | 2022-2024 | Acthar |
| New World Medical,INC. | $111.81 | 2019-2025 | Ahmed Glaucoma Valve, Streamline, Via360 |
| Omeros Corporation | $93.93 | 2019-2020 | |
| Glaukos Corporation | $81.46 | 2019-2025 | Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $78.38 | 2020-2021 | |
| Sight Sciences, INC. | $72.54 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $65.93 | 2022-2024 | Xiidra, Envista Mx60 Iol |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $54.29 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $53.47 | 2021-2023 | |
| Dompe US, INC. | $43.97 | 2019-2025 | Oxervate |
| Ani Pharmaceuticals, INC. | $40.46 | 2023-2025 | Purified Cortrophin Gel |
| Eyevance Pharmaceuticals LLC | $38.75 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $38.37 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.85 | 2022 | |
| Rayner Intraocular Lenses Limited | $37.67 | 2024-2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Rxsight INC | $36.73 | 2022-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Amgen INC. | $30.87 | 2024 | Tepezza |
| Mallinckrodt Enterprises LLC | $27.79 | 2019 | |
| Harrow Eye, LLC | $21.30 | 2023 | Iheezo |
| Spark Therapeutics, INC. | $13.37 | 2021 | |
| Lombart Brothers, INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Tenkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.